The Meager Benefits of the DePuy Attune Revision Knee Replacement Device

DePuy Knee Lawsuit News

Johnson & Johnson subsidiary DePuy Synthes is not overselling the benefits of their knee replacement devices any longer

Tuesday, September 25, 2018 - "Underachiever" would be an accurate one-word review of the newly marketed DePuy Attune Revision Knee Replacement Device. The company has been forced by consumer complaints to dial back their expectations rather than repeat the claims of the original DePuy Attune Knee Replacement Device that boasted that a patient's life will be back to normal in no time. The DePuy Attune "Revision" Knee Replacement device that is currently being marketed to the public offers little in the way of guarantees of leading a normal life. The company claims that the Attune Revision knee "is designed to work with the patient's anatomy so it can deliver stability in motion during activities such as stair climbing, walking uphill or downhill and getting up from a chair." Such a statement is also a glaring admission of the shortcomings of the original DePuy Attune knee device. Why would a company issue a replacement product if the original delivered on the promises the company made?

The DePuy Revision Knee addresses the complaints that patients have made that have forced them to consult DePuy knee replacement lawyers and to file lawsuits against the company. The new knee has a "shock absorber" function that allows flexibility in the artificial joint rather than transfer that torque to the point where the device is attached to the more delicate connection with the tibia. Such tibial baseplate loosening due to debonding of the cement used to attach the knee to the tibia is the complaint most often made of the device. What the DePuy Revision knee fails to address, however, is that the majority of people that comprise knee replacement's target market, senior citizens with osteoarthritis pain, do not have the physical capacity nor the bone structure to adapt to the stress and strain of a new knee joint. DePuy even warns that "age" should be a consideration when a doctor advises a patient to have knee replacement surgery although the company provides no guidance as to what that maximum age may be. A patient's weight is also a consideration because the knee is required to carry a person's full weight repeatedly with every step they take. Once again the warning fails to state the maximum weight for knee replacement surgery consideration. One could also argue that the statement "recovery takes time" is misleading in that the company does not recommend just how much time knee replacement recovery takes. Instead, DePuy is vague and ambiguous when warning patients of the potential for knee replacement failure. The DePuy website's important safety information states the following: "As with any medical treatment, individual results may vary. The performance of knee replacements depends on your age, weight, activity level, and other factors. There are potential risks, and recovery takes time. People with conditions limiting rehabilitation should not have this surgery. Only an orthopedic surgeon can determine if knee replacement is right for you." DePuy knee attorneys with successful DePuy lawsuit history will provide a free case review to persons who suffered from early failure of a DePuy knee and who were forced to undergo revision surgery.

More Recent DePuy Knee Lawsuit News:

No-Cost, No-Obligation DePuy Lawsuit Case Review If You or a Loved One Suffered from DePuy Knee Complications

Onder, Shelton, O'Leary & Peterson, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O'Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm won $197 million in three talcum powder ovarian cancer lawsuits in St. Louis in 2016 and other law firms throughout the nation often seek its experience and expertise on complex litigation.